Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 45, 2011 - Issue 2
Submit an article Journal homepage
375
Views
61
CrossRef citations to date
0
Altmetric
Urology

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: Correlation with histopathology

Thor Knak Jensen Department of UrologyCorrespondence[email protected]
,
Per Holt Department of Urology
,
Oke Gerke PET & Cyclotron Unit, Department of Nuclear Medicine; Department of Biostatistics, University of Southern Denmark, Odense, Denmark
,
Morten Riehmann Department of Urology
,
Birgitte Svolgaard Department of Radiology
,
Niels Marcussen Department of Clinical Pathology, Odense University Hospital, Odense, Denmark
&
Kirsten Bouchelouche PET & Cyclotron Unit, Department of Nuclear Medicine; Cancer & Molecular Imaging Unit, Research Division of Clinical Biochemistry, Koege Hospital University of Copenhagen, Koege, Denmark
 show all
Pages 122-128 | Received 27 Mar 2010, Accepted 27 Oct 2010, Published online: 13 Jan 2011

Citations (61)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Abdulmajeed Aydh, Mohammad Abufaraj, Keiichiro Mori, Fahad Quhal, Benjamin Pradere, Reza Sari Motlagh, Hadi Mostafaei, Pierre I. Karakiewicz & Shahrokh F. Shariat. (2021) Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review. Arab Journal of Urology 19:1, pages 59-66.
Read now
Ho Yub Yoon, In Ho Chang, Yoon Tae Goo, Chang Hyun Kim, Tae Hoon Kang, Soo-Yeon Kim, Sang Jin Lee, Seh Hyon Song, Young Mi Whang & Young Wook Choi. (2019) Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel. International Journal of Nanomedicine 14, pages 6249-6268.
Read now

Articles from other publishers (59)

Andrzej Dłubak, Jakub Karwacki, Katarzyna Logoń, Paulina Tomecka, Kinga Brawańska, Wojciech Krajewski, Tomasz Szydełko & Bartosz Małkiewicz. (2023) Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives. Current Oncology Reports 25:11, pages 1327-1344.
Crossref
Mara Bacchiani, Vincenzo Salamone, Eleana Massaro, Alessandro Sandulli, Riccardo Mariottini, Anna Cadenar, Fabrizio Di Maida, Benjamin Pradere, Laura Mertens, Mattia Longoni, Wojciech Krajewski, Francesco Del Giudice, David D’Andrea, Ekaterina Laukhtina, Shahrokh Shariat, Andrea Minervini, Marco Moschini & Andrea Mari. (2023) Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence. Cancers 15:11, pages 2951.
Crossref
Kirsten Bouchelouche. (2022) PET/CT in Bladder Cancer: An Update. Seminars in Nuclear Medicine 52:4, pages 475-485.
Crossref
Kirsten Bouchelouche. 2020. Nuclear Oncology. Nuclear Oncology 1 49 .
Kirsten Bouchelouche. 2020. Nuclear Oncology. Nuclear Oncology 1 49 .
Kirsten Bouchelouche. 2022. Nuclear Oncology. Nuclear Oncology 975 1022 .
Mohamad Moussa, Mohamad Abou Chakra, Wajih Saad, Athanasios Dellis & Athanasios Papatsoris. (2021) The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer. Urologic Oncology: Seminars and Original Investigations 39:12, pages 833.e9-833.e17.
Crossref
Valérie Fonteyne, K. De Man, K. Decaestecker, P. De Visschere, P. Dirix, G. De Meerleer, C. Berghen, P. Ost & G. Villeirs. (2020) PET–CT for staging patients with muscle invasive bladder cancer: is it more than just a fancy tool?. Clinical and Translational Imaging 9:1, pages 83-94.
Crossref
Jorge Daza & John P. Sfakianos. 2021. Interventional Urology. Interventional Urology 441 455 .
Sanchia S. Goonewardene, Karen Ventii, Amit Bahl, Raj Persad, Hanif Motiwala & David AlbalaSanchia S. Goonewardene, Karen Ventii, Amit Bahl, Raj Persad, Hanif Motiwala & David Albala. 2021. Management of Muscle Invasive Bladder Cancer. Management of Muscle Invasive Bladder Cancer 121 126 .
Antoine Girard, Helena Vila Reyes, Hiram Shaish, Jean-François Grellier, Laurent Dercle, Pierre-Yves Salaün, Olivier Delcroix & Mathieu Rouanne. (2020) The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma. Frontiers in Oncology 10.
Crossref
Patrick J. Eulitt, Ersan Altun, Arif Sheikh, Terence Z. Wong, Michael E. Woods, Tracy L. Rose, Eric M. Wallen, Raj S. Pruthi, Angela B. Smith, Matthew E. Nielsen, Young E. Whang, William Y. Kim, Paul A. Godley, Ethan M. Basch, Grace U. David, Juanita Ramirez, Allison M. Deal, W. Kimryn Rathmell, Ronald C. Chen, Marc A. Bjurlin, Weili Lin, Joseph K. Lee & Matthew I. Milowsky. (2020) Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC). Clinical Genitourinary Cancer 18:5, pages 378-386.e1.
Crossref
Sarah M.H. Einerhand, Erik J. van Gennep, Laura S. Mertens, Kees Hendricksen, Maarten L. Donswijk, Henk G. van der Poel & Bas W.G. van Rhijn. (2020) 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer. Current Opinion in Urology Publish Ahead of Print.
Crossref
Avinash Maganty, Robert M. TurnerIIII, Jonathan G. Yabes, Dwight E. Heron, Jeffrey R. Gingrich, Benjamin J. Davies & Bruce L. Jacobs. (2020) Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy. European Journal of Cancer Care 29:4.
Crossref
Kirsten Bouchelouche & Peter L. Choyke. 2020. Clinical Nuclear Medicine. Clinical Nuclear Medicine 731 754 .
Paolo Castelluci, Stefano Fanti, Stefano Bracci, Valeria Panebianco, Alessio Giuseppe Morganti & Rezarta Frakulli. 2020. Imaging and Interventional Radiology for Radiation Oncology. Imaging and Interventional Radiology for Radiation Oncology 221 254 .
Jason R. Gee. 2020. Renal Cancer. Renal Cancer 325 343 .
Jack Crozier, Nathan Papa, Marlon Perera, Brian Ngo, Damien Bolton, Shomik Sengupta & Nathan Lawrentschuk. (2018) Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. World Journal of Urology 37:4, pages 667-690.
Crossref
A. Girard, J.F. Grellier & P.Y. Salaün. (2019) Cancers de la vessie. Médecine Nucléaire 43:1, pages 69-76.
Crossref
Matthew Mossanen, Steven L. Chang, Simon Kimm, Guru P. Sonpavde & Adam S. Kibel. (2018) Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urologic Clinics of North America 45:2, pages 143-154.
Crossref
Anna Rita Cervino, Lea Cuppari, Pasquale Reccia, Marta Burei, Giorgio Saladini & Laura Evangelista. (2018) The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis. Clinical and Translational Imaging 6:2, pages 77-89.
Crossref
Sungmin WooChong Hyun SuhSang Youn KimJeong Yeon ChoSeung Hyup Kim. (2018) The Diagnostic Performance of MRI for Detection of Lymph Node Metastasis in Bladder and Prostate Cancer: An Updated Systematic Review and Diagnostic Meta-Analysis. American Journal of Roentgenology 210:3, pages W95-W109.
Crossref
Hong Ku Ha, Phillip J. Koo & Seong-Jang Kim. (2018) Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis. Oncology 95:1, pages 31-38.
Crossref
Nessn H. Azawi, Kasper Drimer Berg, Andreas Key Milan Thamsborg, Claus Dahl, Jan Viberg Jepsen, Bjarne Kroman-Andersen, Johan Poulsen, Helle Handler Petersen, L. Henning Olsen & Jørgen Bjerggaard Jensen. (2017) Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?. International Urology and Nephrology 49:10, pages 1785-1792.
Crossref
Renate Pichler, Tobias De Zordo, Josef Fritz, Alexander Kroiss, Friedrich Aigner, Isabel Heidegger, Irene Virgolini, Wolfgang Horninger & Christian Uprimny. (2017) Pelvic Lymph Node Staging by Combined 18 F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy. Clinical Genitourinary Cancer 15:3, pages e387-e395.
Crossref
Jorge D. Oldan, Shetal N. Shah & Tracy Lynn Rose. (2017) Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers. Magnetic Resonance Imaging Clinics of North America 25:2, pages 335-350.
Crossref
Bernard H. Bochner, Donna E. Hansel, Jason A. Efstathiou, Badrinath Konety, Cheryl T. Lee, James M. McKiernan, Elizabeth R. Plimack, Victor E. Reuter, Srikala Sridhar, Raghunandan Vikram & Walter M. Stadler. 2017. AJCC Cancer Staging Manual. AJCC Cancer Staging Manual 765 773 .
Kirsten Bouchelouche. 2017. Nuclear Oncology. Nuclear Oncology 839 881 .
Cory M. Hugen, Vinay Duddalwar & Siamak Daneshmand. (2016) Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy. Current Urology Reports 17:9.
Crossref
Ayman Soubra, Daniel Hayward, Philipp Dahm, Robert Goldfarb, Jerry Froehlich, Gautam Jha & Badrinath R. Konety. (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World Journal of Urology 34:9, pages 1229-1237.
Crossref
Sameh Hijazi, Birgit Meller, Conrad Leitsmann, Arne Strauss, Christian Ritter, Joachim Lotz, Johannis Meller, Lutz Trojan & Carsten-Oliver Sahlmann. (2016) See the unseen: Mesorectal lymph node metastases in prostate cancer. The Prostate 76:8, pages 776-780.
Crossref
Philip L. Ho, Daniel L. Willis, Jeevitha Patil, Lianchun Xiao, Stephen B. Williams, Jonathan J. Melquist, Karen Tart, Sahil Parikh, Jay B. Shah, Scott E. Delacroix, Neema Navai, Arlene Siefker-Radtke, Colin P. Dinney, Louis L. Pisters & Ashish M. Kamat. (2016) Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urologic Oncology: Seminars and Original Investigations 34:2, pages 59.e1-59.e8.
Crossref
Hakan Öztürk. (2015) Comparing RECIST with EORTC criteria in metastatic bladder cancer. Journal of Cancer Research and Clinical Oncology 142:1, pages 187-194.
Crossref
Kirsten Bouchelouche. 2016. Nuclear Oncology. Nuclear Oncology 1 43 .
Hakan Öztürk. (2015) Detecting Metastatic Bladder Cancer Using <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography. Cancer Research and Treatment 47:4, pages 834-843.
Crossref
In Gab Jeong, Sungwoo Hong, Dalsan You, Jun Hyuk Hong, Hanjong Ahn & Choung-Soo Kim. (2015) FDG PET–CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy. Annals of Surgical Oncology 22:9, pages 3150-3156.
Crossref
Kirsten Bouchelouche & Peter L. Choyke. (2015) PET/Computed Tomography in Renal, Bladder, and Testicular Cancer. PET Clinics 10:3, pages 361-374.
Crossref
Huojun Zhang, Wei Xing, Qinqin Kang, Chao Chen, Linhui Wang & Jianping Lu. (2015) Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis. Tumor Biology 36:5, pages 3209-3214.
Crossref
Adam C. Reese & Mark Schoenberg. 2015. Management of Bladder Cancer. Management of Bladder Cancer 449 455 .
M. Rouanne, A. Girma, Y. Neuzillet, D. Vilain, C. Radulescu, N. Letang, L. Yonneau, J.-M. Hervé, H. Botto, E. Le Stanc & T. Lebret. (2014) Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. European Journal of Surgical Oncology (EJSO) 40:12, pages 1724-1730.
Crossref
Henry Goodfellow, Zaid Viney, Paul Hughes, Sheila Rankin, Giles Rottenberg, Simon Hughes, Felicity Evison, Prokar Dasgupta, Timothy O'Brien & Muhammad Shamim Khan. (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU International, pages n/a-n/a.
Crossref
Tobias Maurer, Thomas Horn, Michael Souvatzoglou, Matthias Eiber, Ambros J. Beer, Matthias M. Heck, Bernhard Haller, Jürgen E. Gschwend, Markus Schwaiger, Uwe Treiber & Bernd J. Krause. (2014) Prognostic Value of <sup>11</sup>C-Choline PET/CT and CT for Predicting Survival of Bladder Cancer Patients Treated with Radical Cystectomy. Urologia Internationalis 93:2, pages 207-213.
Crossref
Tobias Maurer, Thomas Horn, Matthias Heck, Jürgen Gschwend, Matthias Eiber & Ambros Beer. (2013) Current Staging Procedures in Urinary Bladder Cancer. Diagnostics 3:3, pages 315-324.
Crossref
Eugenio Brunocilla, Remigio Pernetti, Riccardo Schiavina, Marco Borghesi, Valerio Vagnoni, Giovanni Christian Rocca, Filippo Borgatti, Sergio Concetti & Giuseppe Martorana. (2013) The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer. International Urology and Nephrology 45:3, pages 711-719.
Crossref
Lukas Lusuardi & Günter Janetschek. (2013) Update on use of Enhanced Imaging to Optimize Lymphadenectomy in Patients Undergoing Minimally Invasive Surgery for Urothelial Cancer of the Bladder. Current Urology Reports 14:2, pages 124-129.
Crossref
Yang Li, Zhong-qing Yang, Hui Ye, Lin Qi & Jun-wu Hu. (2013) Application of 18F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions. Journal of Huazhong University of Science and Technology [Medical Sciences] 33:2, pages 234-237.
Crossref
T. Maurer, T. Horn, A.J. Beer, M. Eiber & J.E. Gschwend. (2013) Funktionelle Bildgebung beim HarnblasenkarzinomFunctional imaging in bladder cancer. Der Urologe 52:4, pages 509-514.
Crossref
Masahiro Matsuki, Atsushi Takahashi, Shuuichi Katou, Akio Takayanagi, Yoshio Takagi & Kimio Kamata. (2013) PATHOLOGICAL COMPLETE RESPONSE TO GEMCITABINE AND CISPLATIN CHEMOTHERAPY FOR ADVANCED UPPER TRACT UROTHELIAL CARCINOMA: A CASE REPORT. The Japanese Journal of Urology 104:1, pages 33-37.
Crossref
Huanjun Wang, Yan Guo, Xuhui Zhou & Dong Yang. (2013) Urinary Bladder Cancer: The Current and Potential Role of MR Imaging in Non-Distant Metastatic Lesions. Journal of Cancer Therapy 04:02, pages 504-512.
Crossref
C. Roy, E. Rust & M. Ohana. (2013) Imagerie dans l’étude des métastases ganglionnaires des tumeurs génito-urinaires pelviennes de l’adulte. EMC - Radiologie et imagerie médicale - Génito-urinaire - Gynéco-obstétricale - Mammaire 8:1, pages 1-20.
Crossref
Jason R. Gee. 2013. Renal Cancer. Renal Cancer 359 372 .
David A. Green, Matthieu Durand, Naveen Gumpeni, Michael Rink, Eugene K. Cha, Pierre I. Karakiewicz, Douglas S. Scherr & Shahrokh F. Shariat. (2012) Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques. BJU International 110:10, pages 1463-1470.
Crossref
Andrei S. Purysko, Hilton M. Leão Filho & Brian R. Herts. (2012) Radiologic Imaging of Patients With Bladder Cancer. Seminars in Oncology 39:5, pages 543-558.
Crossref
Ferga C. Gleeson, Jonathan E. Clain, R. Jeffrey Karnes, Elizabeth Rajan, Mark D. Topazian, Kenneth K. Wang & Michael J. Levy. (2012) Endoscopic-Ultrasound-Guided Tissue Sampling Facilitates the Detection of Local Recurrence and Extra Pelvic Metastasis in Pelvic Urologic Malignancy. Diagnostic and Therapeutic Endoscopy 2012, pages 1-6.
Crossref
J. Müller, M. Schrader, A.J. Schrader, M. Höpfner & F. Zengerling. (2012) Stellenwert der Positronenemissionstomographie bei urologischen TumorenValue of positron emission tomography in urological neoplasms. Der Urologe 51:3, pages 331-340.
Crossref
Christopher J. Weight & Mathew T. Gettman. (2011) The Emerging Role of Lymphadenectomy in Upper Tract Urothelial Carcinoma. Urologic Clinics of North America 38:4, pages 429-437.
Crossref
Victoria Chernyak. (2011) Novel Imaging Modalities for Lymph Node Imaging in Urologic Oncology. Urologic Clinics of North America 38:4, pages 471-481.
Crossref
Normand Blais. (2011) Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease. Current Opinion in Supportive & Palliative Care 5:3, pages 192-198.
Crossref
Kelvin A. Moses, Jingbo Zhang, Hedvig Hricak & Bernard H. Bochner. (2011) Bladder cancer imaging. Current Opinion in Urology 21:5, pages 393-397.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.